| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.nidanhealthcare.co.in | |
| Market Cap | 40.31 Cr. | |
| Enterprise Value(EV) | 54.56 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.55 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 11.39 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 66.40 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 49.96 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 0.58 | Calculated using Price: 29.00 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.39 Cr. | 13,900,000 Shares |
| FaceValue | 10 | |
| About Nidan Laboratories And Healthcare Ltd. | ||
| The company offers diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports. | ||
| 1 Day |
|
|
| 1 Week |
|
-1.69% |
| 1 Month |
|
-1.86% |
| 3 Month |
|
-25.35% |
| 6 Month |
|
-9.94% |
| 1 Year |
|
-26.11% |
| 2 Year |
|
-34.68% |
| 5 Year |
|
|
| 10 Year |
|
| 5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 2.17 | 6.7 | 18.9 | 6.72 | 5.23 | |
| Return on Capital Employed (%) | 11.71 | 10.15 | 13.98 | 10.52 | 8.5 | |
| Return on Assets (%) | 0.52 | 1.63 | 4.68 | 3.76 | 4.12 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 10 | 11 | 13 | 66 | 69 | 71 | |
| Non Curr. Liab. | 32 | 34 | 14 | 9 | 5 | 4 | |
| Curr. Liab. | 1 | 0 | 26 | 13 | 10 | 13 | |
| Minority Int. | |||||||
| Equity & Liab. | 43 | 45 | 53 | 88 | 84 | 88 | |
| Non Curr. Assets | 24 | 21 | 31 | 63 | 63 | 68 | |
| Curr. Assets | 19 | 24 | 23 | 25 | 21 | 20 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 43 | 45 | 53 | 88 | 84 | 88 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 20 | 21 | 20 | 30 | 24 | |
| Other Income | 0 | 0 | 1 | 0 | 3 | |
| Total Income | 20 | 21 | 21 | 30 | 28 | |
| Total Expenditure | -12 | -14 | -11 | -20 | -17 | |
| PBIDT | 8 | 8 | 10 | 10 | 10 | |
| Interest | -5 | -4 | -3 | -3 | -2 | |
| Depreciation | -3 | -3 | -3 | -3 | -3 | |
| Taxation | -1 | -2 | -1 | |||
| Exceptional Items | ||||||
| PAT | 0 | 1 | 2 | 3 | 4 | |
| Adjusted EPS | 0 | 1 | 2 | 2 | 3 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 9 | 5 | 4 | 8 | 14 | |
| Cash Fr. Inv. | 1 | 0 | -3 | -36 | -3 | |
| Cash Fr. Finan. | -6 | -2 | -1 | 29 | -11 | |
| Net Change | 4 | 3 | 0 | 1 | 0 | |
| Cash & Cash Eqvt | 4 | 7 | 7 | 8 | 8 |
|
Fri, 12 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Nidan Laboratories And Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
Wed, 10 Apr 2024
Trading Window Nidan Laboratories And Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
Thu, 22 Feb 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent NIDAN LABORATORIES AND HEALTHCARE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| Thu, 18 Apr 2024 |
High Delivery Percentage
|
Opening at High
|
Close Within 52 Week Low Zone
|
High Decrease in 3 Months
|
MFI Below 20
|
